INTRA CELLULAR THERAPIES INC filings

SEC filings by INTRA CELLULAR THERAPIES INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13VANGUARD GROUP INCIntra-Cellular Therapies, Inc.9,094,3029.4%EDGAR
SC 13G/A2024-02-09FMR LLCIntra-Cellular Therapies, Inc.11,457,69411.9%EDGAR
SC 13G/A2024-02-09WASATCH ADVISORS LPIntra-Cellular Therapies, Inc.--EDGAR
SC 13G/A2024-02-08WELLINGTON MANAGEMENT GROUP LLPIntra-Cellular Therapies, Inc.1,763,4751.8%EDGAR
SC 13G/A2024-01-25BlackRock Inc.Intra-Cellular Therapies, Inc.8,192,9878.5%EDGAR
SC 13G/A2023-02-09FMR LLCIntra-Cellular Therapies, Inc.12,028,78912.7%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCIntra-Cellular Therapies, Inc.8,319,2498.8%EDGAR
SC 13G2023-02-06WELLINGTON MANAGEMENT GROUP LLPIntra-Cellular Therapies, Inc.5,409,6855.7%EDGAR
SC 13G/A2023-02-03BlackRock Inc.Intra-Cellular Therapies, Inc.7,449,5297.9%EDGAR
SC 13G/A2023-01-10WASATCH ADVISORS INCIntra-Cellular Therapies, Inc.--EDGAR
SC 13G/A2022-02-10WASATCH ADVISORS INCIntra-Cellular Therapies, Inc.--EDGAR
SC 13G/A2022-02-10VANGUARD GROUP INCIntra-Cellular Therapies, Inc.6,876,2018.4%EDGAR
SC 13G/A2022-02-09FMR LLCIntra-Cellular Therapies, Inc.10,961,96913.5%EDGAR
SC 13G/A2022-02-03BlackRock Inc.Intra-Cellular Therapies, Inc.5,721,7667.0%EDGAR
SC 13G/A2021-12-02WASATCH ADVISORS INCIntra-Cellular Therapies, Inc.--EDGAR
SC 13G/A2021-02-12BB BIOTECH AGIntra-Cellular Therapies, Inc.3,538,4194.4%EDGAR
SC 13G/A2021-02-10VANGUARD GROUP INCIntra-Cellular Therapies, Inc.6,481,3448.1%EDGAR
SC 13G2021-02-09WASATCH ADVISORS INCIntra-Cellular Therapies, Inc.--EDGAR
SC 13G/A2021-02-08FMR LLCIntra-Cellular Therapies, Inc.12,023,58415.0%EDGAR
SC 13G/A2021-01-29BlackRock Inc.Intra-Cellular Therapies, Inc.5,898,5687.4%EDGAR